Term
What are the lab tests that evaluate for glomerular function?
|
|
Definition
GFR
BUN
Serum Creatinine
Creatinine Clearance
|
|
|
Term
What is considered the best measure of renal function? Normal value? |
|
Definition
|
|
Term
What is a potentially misleading test of renal function? Why?
According to Ron, regardless of other possible causes, if the BUN is above ___ then renal issues exist. |
|
Definition
BUN
Can be elevated by reasons other than renal failure such as:
high protein diet
GI bleeding
dehydration
exercise
increased catabolism
steroids
BUN above 50
(usually reflect decr GFR) |
|
|
Term
How is creatinine produced?
How is it filtered? |
|
Definition
produced at a relatively steady rate by hepatic conversion of skeletal muscle creatine
freely filtered at the glomerulus |
|
|
Term
What are the normal values of serum creatinine for females & males?
What happens this level in the elderly?
The serum creatinine is slow or fast to reflect acute changes in GFR. |
|
Definition
female: 0.6-1.0mg/dl
male: 0.8-1.3mg/dl
elderly: decreased secondary to decr muscle mass
*so even slight elevations in the elderly can be an issue
slow to reflect acute changes in GFR |
|
|
Term
What is the most reliable measure of GFR? |
|
Definition
|
|
Term
*How is creatinine clearance calculated?
What units ? |
|
Definition
creatinine clearance (ml/min)=
[(140-age) X LBM (kg)] / [plasma creatinine (mg/dl) X 72]
(LBM=lean body mass) |
|
|
Term
*How is the measured value of creatinine clearance determined? |
|
Definition
creatinine clearance (mg/ml)=
{[Urinary Creatinine (mg/100ml)]/[Plasma Creatinine (mg/100mL)}
X
Urine Volume (ml/min) |
|
|
Term
What are the normal values for creatinine clearance for females and males?
What happens to it as we age? |
|
Definition
female: 85-125ml/min
male: 95-140ml/min
decreases with age |
|
|
Term
What is urine specific gravity an assessment of?
Normal specific gravity of plasma and urine?
What if both of the above are the same? |
|
Definition
assessment of urine concentrating ability
plasma: 1.010 (290 mOsm/kg)
urine specific gravity: > 1.018
implies adequate concentrating ability
If they are the same, there is a problem...kidneys are not concentrating at all. |
|
|
Term
What is the normal for proteinuria?
Causes of incr proteinuria? |
|
Definition
normal ≤150mg/day
Causes:
glomerular damage
failure of reabsorption
excessive plasma proteins
orthostatic proteinuria (common in teenagers - benign finding)
microalbuminuria (early indicator of diabetic nephropathy) |
|
|
Term
What are tests of tubular function? |
|
Definition
urine specific gravity
proteinuria
urinary sodium
glycosuria |
|
|
Term
What does a urinary sodium ≥40 mEq/L reflect? |
|
Definition
reflects decreased ability of tubules to conserve sodium |
|
|
Term
Why does glucose appear in the urine (Glycosuria)? |
|
Definition
tubules unable to reabsorb enough glucose to compensate for an increased load (typically r/t diabetes) and it is spilled in the urine |
|
|
Term
What are additional tests that can be done to assess renal function? |
|
Definition
Urinalysis
CBC
Electrolytes
pH
EKG |
|
|
Term
What does urinalysis detect? |
|
Definition
protein
glucose
blood
leukocytes
pH
specific gravity
presence of casts
crystals
microorganisms |
|
|
Term
CBC
Anemia is secondary to _______ ________ |
|
Definition
anemia secondary to decreased erythropoetin |
|
|
Term
Electrolytes typically remain _____ until renal disease _______ |
|
Definition
Electrolytes typically remain normal until disease advanced |
|
|
Term
Kidneys required to excrete_______acids
Inability to excrete an _____ urine from renal insufficiency results in increased _____ ph and decreased _____ ph. |
|
Definition
Kidneys required to excrete non-volatile acids
(the only volatile acid in the body is CO2 and can be excreted via exhalation, all other acids in the body, like lactic acid, are non-volatile or fixed meaning they have to be excreted through the kidneys)
Inability to excrete an acidic urine from renal insufficiency results in increased urine pH and decreased serum pH |
|
|
Term
What EKG changes can be seen with renal dysfunction? |
|
Definition
changes associated with hyperkalemia:
peaked T waves
prolonged PR interval and QRS
AV conduction delay
loss of P waves
V-Fib
asystole |
|
|
Term
Neurohormonal Reglulation
How does the body protect against hypovolemia & hypotension?
What are 3 mechanisms? |
|
Definition
Protect against hypovolemia and hypotension through:
vasoconstriction and salt and water retention
Sympathoadrenal Axis
Renin-Angiotensin-Aldosterone
Arginine-Vasopression (ADH)
|
|
|
Term
What do the "vasoconstrictor systems" do to the following:
RBF
GFR
Urine flow
Na excretion |
|
Definition
decreases them all:
decr RBF
decr GFR
decr Urine flow
decr Na excretion |
|
|
Term
Neurohormonal Reglulation
How does the body protect against hypervolemia and hypertension?
What are 3 mediators of this? |
|
Definition
Protect against hypervolemia and hypertension through:
vasodilation and salt & water excretion
BradyKinins
Atrial Natiuretic Peptide (ANP)
Prostaglandins
KAP
|
|
|
Term
What effects do the "vasodilator systems" have on the following:
RBF
GFR
Urine flow
Na excretion |
|
Definition
Increase in all:
incr RBF
incr GFR
incr Urine flow
incr Na excretion |
|
|
Term
*How does anesthesia affect the neurohormonal systems? |
|
Definition
insignificant effects of anesthesia other than those mediated by hemodynamic changes |
|
|
Term
*How does surgery and trauma affect the neurohormonal regualtion systems?
How long does this last?
T/F anesthesia in and of itself will not necessarily cause damage to someones kidneys, rather the surgical trauma causes potential for more issues? |
|
Definition
surgery and trauma may produce significant vasoconstriction and salt and water retention
lasting for several days
True; per Ron |
|
|
Term
Surgery & trauma lead to vasoconstriction and salt & water retention that lasts for several days.
What can this lead to?
Vasoconstriction predisposes the kidneys to additional _______.
|
|
Definition
Leads to postop oliguria & edema
Vasoconstriction predisposes the kidneys to additional injury |
|
|
Term
What mediates/causes the sympathetic effects in the sympathoadrenal axis? |
|
Definition
epinephrine and norepinephrine |
|
|
Term
Sympathoadrenal axis
What senses decreased BP? Where are these receptors located?
What does this result in? |
|
Definition
decreased BP sensed by baroreceptors
in aortic arch/carotid sinus
results in increased adrenergic output |
|
|
Term
Sympathoadrenal axis
Where are the G-protein receptors involved in the SNS mechanism located? (2)
What do these mediate/cause r/t the sympathoadrenal axis?
What stimulates these G-protien receptors? |
|
Definition
vascular smooth muscle and mesangium
mediate vasoconstriction
adrenergic stimulation, as well as:
Angiotension II
vasopression
leukotrienes
and others |
|
|
Term
How does the parasympathetic system affect the kidneys? |
|
Definition
kidneys lack parasympathetic innervation |
|
|
Term
What are the predominantlly a-adrenergic effects of sympathoadrenal stimulation?
What are 4 a-adrenergic agonists? |
|
Definition
results in vasoconstriction
NE
epi
phenylephrine
high-dose dopamine
(Dopamine >10 mg/kg/min: alpha effects predominate; arterial vasoconstriction & BP ensue)
|
|
|
Term
What are the B-adrenergic effects of sympathoadrenal stimulation?
What are the intrinsic renal effects d/t B-adrenergic stimulation?
Name 2 B-agonists |
|
Definition
increase RBF secondary to increased CO
intrinsic renal effects unclear
Isoproterenol
Dobutamine
(Dopamine 5-10 m g/kg/min: B2 effects predominate; cardiac contractility & HR) |
|
|
Term
What are the renal effects of sympathoadrenal stimulation with Dopaminergic agonists?
Name 3 dopaminergic agonists |
|
Definition
selectivey increase RBF
may oppose a-adrenergic induced vasoconstriction
Dopexamine
fenoldopam,
low-dose dopamine
(Dopamine <5 mg/kg/min predominantly stimulates DA1 & DA2 receptors in renal, mesenteric & coronary beds; = vasodilatation) |
|
|
Term
Where is Aldosterone released from?
in response to?
see slide 15 for RAAS |
|
Definition
released from adrenal cortex in response to:
Angiotensin II
Hyponatremia
Hyperkalemia |
|
|
Term
How does Aldosterone influence blood volume? |
|
Definition
increases blood volume by:
active Na absorption
passive H2O absorption |
|
|
Term
Why is Aldosterone's effect delayed?
How long does it take to start working? |
|
Definition
acts via mRNA transcription, so effect is not immediate but delayed 1-2 hours
(mRNA transcription in tubule cells causes increased activity of the NaK pump and formation of ENaC channels) |
|
|
Term
What does Arginine Vasopressin regulate?
Where is it synthesized and stored? |
|
Definition
regulates urine volume & osmolality
synthesized in hypothalamus
stored in pituitary |
|
|
Term
What is AVP released in response to?
Per Ron which is the most potent stimulator of AVP release? |
|
Definition
increasing plasma osmolality (osmoreceptors)
decreased intravascular volume & arterial
hypotension (stress)
angio II
Aldosterone
Arterial hypotension |
|
|
Term
How does AVP help maintain adequate glomerular filtration?
look at slide 18 about stimulus for AVP secretion |
|
Definition
constriction of efferent arterioles
little to no effect on afferent arterioles |
|
|
Term
How do prostaglandins affect the kidneys? (3) |
|
Definition
promote renal vasodilation
maintain intrarenal hemodynamics
enhance sodium and water excretion |
|
|
Term
How do kinins affect the renal system? |
|
Definition
stimulate PLA2
act as vasodilators enhancing the action of prostaglandins |
|
|
Term
In addition to kinins, what can stimulate PLA2?
see slide 20 |
|
Definition
hypotension
ischemia
angiotensin II
norepi
AVP
HI ANA |
|
|
Term
Where is ANP released from?
In response to what?
It ____ vascular smooth muscle via formation of _____? |
|
Definition
released from atrial myocytes in response to increased atrial volume & subsequent wall stretch
It dilates vascular smooth muscle via formation of cGMP |
|
|
Term
ANP at the ___ receptor
competitively blocks ____
non-competitvely blocks ___ |
|
Definition
ANP at the PLC receptor
competitively blocks NE
non-competitively blocks angiotensin II |
|
|
Term
What does ANP inhibit? (3) |
|
Definition
renin secretion
aldosterone release
AVP secretion |
|
|
Term
How may dopamine produce renal protection?
Why is effectiveness limited?
What is the interpatient variability?
Bottom Line? |
|
Definition
DA1 effects - increased RBF
B-adrenergic effects - increased CO & renal perfusion
Effectiveness limited by its mixed adrenergic effects
Significant (30-fold) interpatient variability in plasma levels
bottom line: useful as an inotropic agent when oliguria persists despite adequate intravascular volume
(no good evidence that it helps renal, but it is still used) |
|
|
Term
What is Dopexamine?
What disease process is it useful in? Why? |
|
Definition
Dopaminergic agonist
synthetic analog of dopamine
has found use in CHF producing:
afterload reduction
increased RBF |
|
|
Term
What is Fenoldopam and what is it approved for?
At _____ mcg/kg/min produces a _____ increase in ___ and ____? |
|
Definition
Dopaminergic agonist
selective DA1 receptor agonist
approved for short-term treatment of severe hypertension, particularly renovascular
At 0.03-0.3 mcg/kg/min produces a dose-related increase in RBF and natriuresis |
|
|
Term
Prostaglandins & renal protection:
counteract?
maintain perfusion of?
Synthetic PGE1 has been shown to prevent ____-induced ____ in animal models? |
|
Definition
counteract the vasoconstrictive effects of NE and angiotension II
maintain perfusion of the inner cortex
Synthetic PGE1 has been shown to prevent ischemia-induced ARF in an animal model |
|
|
Term
Ca channel blockers & renal protection:
increase?
interference? |
|
Definition
increase RBF & GFR & induce natriuresis in HTN patients
interference with renal autoregulation may worsen renal function if accompanied by hypotension |
|
|
Term
Atrial natriuretic peptide
animal studies show significant improvement in ___ and ___, with reduction in _______ when given in ATN of both ischemic and nephrotoxic etiology |
|
Definition
animal studies show significant improvement in RBF and GFR, with reduction in renal histologic damage when given in ATN of both ischemic and nephrotoxic etiology |
|
|
Term
Atrial natriuretic peptide
mixed results in humans following multiple multicenter RCTs, varying from marked _____ in survival to _____
-may potentially worsen outcome in ____, as opposed to _____ acute renal failure |
|
Definition
mixed results in humans following multiple multicenter RCTs, varying from marked improvement in survival to no effect
-may potentially worsen outcome in non-oliguric, as opposed to oliguric acute renal failure |
|
|
Term
What are the stages of chronic renal failure? |
|
Definition
1. decreased renal reserve
2. renal insufficiency
3. end-stage renal disease (ESRD) |
|
|
Term
What is the GFR in decreased renal reserve?
Symptoms? |
|
Definition
GFR 60-75% of normal
asymptomatic and often without abnormal lab |
|
|
Term
What is the GFR in renal insufficiency?
symptoms? |
|
Definition
GFR 25-40% of normal
elevated creatinine and BUN, but nocturia may be the only symptom - variable |
|
|
Term
What is the GFR in ESRD?
symptoms? |
|
Definition
GFR< 25% of normal
multiple organ dysfunction, fatal without dialysis |
|
|
Term
What is the most severe form of chronic renal failure?
GFR in in this stage? |
|
Definition
Uremic Syndrome
GFR< 10% of normal |
|
|
Term
What are the major functions that the kidney is no longer able to perform in uremic syndrome? |
|
Definition
Regulatory - extracellular volume and composition
Excretory - elimination of waste products
Secretory |
|
|
Term
What are 2 CV complications that can be seen in CRF? (general) |
|
Definition
Systemic Hypertension
Uremic Pericarditis |
|
|
Term
In CRF, what does systemic HTN represent?
|
|
Definition
Retention of Na and water leading to expansion of intravascular volume
Activation of the RAAS |
|
|
Term
How do we manage retention of Na & water in CRF?
How do we manage activation of the RAAS in CRF? |
|
Definition
-managed with diuretics and/or dialysis to remove volume
RAAS: managed w/ ACEI/ARBs |
|
|
Term
What does HTN contribute to in CRF? |
|
Definition
CHF
coronary artery disease
cerebrovascular disease |
|
|
Term
What is normocytic, normochromic anemia due to in CRF?
How is it treated? |
|
Definition
inadequate production of erythropoietin
effectively treated with human recombinant erythropoietin
desmopressin, cryoprecipitate, conjugated estrogens |
|
|
Term
What test correlates best w/ tendency to bleed?
Are platelet count, PT & PTT always abnormal in CRF?
What 3 thing can be out of whack w/ incr bleeding and CRF? |
|
Definition
Bleeding time
No, platelet count, PT, and PTT may remain normal
1. decreased platelet factor 3
2. abnormal platelet aggregation & adhesiveness
3. impaired prothrombin consumption |
|
|
Term
What are the neurologic symtpoms in CRF?
When will some symptoms improve? Especially which one?
D/t the distal motor weakness seen in many of these pts and their decreased bone mass they have an increased risk for ____ and ____.
see slide 35 r/t renal osteodystrophy |
|
Definition
Wide variation in symptoms ranging from insomnia and irritability to seizures, uremic encephalopathy, and coma
Also may see a symmetrical, distal, sensory & motor neuropathy (may be superimposed on DM neuropathy)
some symptoms will improve with dialysis particularly uremic encephalopathy
Breaks and falls |
|
|
Term
What are the pulmonary changes seen in CRF?
What do these respond to? |
|
Definition
-low press. pulmonary edema secondary to increased permeability of alveolar capillary membranes
-peripheral vascular congestion appearing as butterfly wing distribution on chest film
responds to dialysis |
|
|
Term
What is the tx of HTN associated with CRF? |
|
Definition
aggresive management of hypertension:
ACEI
ARB
B-blockers |
|
|
Term
What should the glycosalated hemoglobin be maintained at for aggressive management of DM? |
|
Definition
|
|
Term
What are other treatments of CRF besides management of HTN and diabetes?
dietary ____ restriction ≤0.6g/kg/day
treatment of anemia w/ ________
ultimately ______ or ________
|
|
Definition
dietary protein restriction ≤0.6g/kg/day
treatment of anemia w/ erythropoietin
ultimately dialysis or transplant |
|
|
Term
What are the general goals for anesthetic drugs when patient has renal issues? (3) |
|
Definition
1. maintain renal blood flow with adequate perfusion pressure
2. suppress vasoconstricting, salt retaining response to surgical stimulation & pain
3. avoid or minimize nephrotoxic insults |
|
|
Term
How does a sympathetic block of T4-T10 w/neuraxis anesthesia affect the renal system? |
|
Definition
Effectively suppresses the sympathoadrenal stress response and release of:
catecholamines
renin
AVP |
|
|
Term
RA & the kidney
RBF and GFR remain adequate as long as... |
|
Definition
RBF and GFR remain adeqate AS LONG AS PERFUSION PRESSURE IS MAINTAINED |
|
|
Term
Do all GA techniques affect GFR and UOP?
What about RBF & FF? Why?
Renal autoregulation with GA? |
|
Definition
all tend to reduce both GFR & UOP but minimal compared to surgical effects per Ron
RBF reduced, but FF maintained or increased likely due to angiotension-induced efferent arteriolar constriction
renal autoregulation typically preserved |
|
|
Term
How do IAs affect RBF & GFR?
How do we decrease this effect? |
|
Definition
mild to moderate reductions in RBF and GFR
attenuated by fluid loading |
|
|
Term
How do high dose opioid GA techniques affect RBF and GFR?
How do they compare to IAs in suppressing the SNS response to surgery? |
|
Definition
minimal effect on RBF and GFR
more effective than volatile in suppressing the vasoconstricting, salt retaining effects of releasing: catecholamines, angiotensin, aldosterone, AVP |
|
|
Term
How do IV induction agents affect RBF?
Exception?
How does this agent affect RBF & UOP? |
|
Definition
produce small decreases in RBF
with the exception of Ketamine which:
increases RBF, decreases UOP likely via sympathetic activation |
|
|
Term
How can IA produce nephrotoxicity?
What fluroide levels produce injury?
____ μm/l rarely induce injury
___ μm/l high incidence of injury |
|
Definition
metabolic breakdown to free flouride ions, producing a tubular lesion resulting in loss of concentrating ability
Peak flouride levels:
<50μm/l rarely induce injury
>150μm/l high incidence of injury |
|
|
Term
What are the fluroide levels of:
Methoxyflurane
Enflurane
Isoflurane
Desflurane |
|
Definition
Methoxyflurane can produce >100μm/l
(no longer available)
Enflurane rarely exceeds 25μm/l
Isoflurane <4μm/l
Desflurane minimal |
|
|
Term
Does Sevo or Enflurance produce more flouride ions?
Is this clinically signifiant? |
|
Definition
greater flouride ion prodution with Sevo than enflurane
but:CLINICALLY SIGNIFICANT FLOURIDE-INDUCED NEPHROTOXICITY NOT PRODUCED WITH SEVO |
|
|
Term
What is Compound A produced from?
Is this clincally significant? |
|
Definition
Degradation of sevo during low flow states through CO2 absorbents
-shown to produce renal injury in animal models
-CLINICALLY SIGNIFICANT RENAL INJURY FOLLOWING LOW-FLOW SEVO NOT REPORTED IN HUMANS |
|
|
Term
What are the FDA recommendations for Sevo? |
|
Definition
FDA guidelines recommend a FGF of >2L/min to inhibit Compound A formation and limit its rebreathing |
|
|
Term
What may positive pressure ventilation & PEEP decrease?
What does the effect correlate with? |
|
Definition
RBF
GFR
Na excretion
UOP
effect correlates with level of airway pressure |
|
|
Term
Mechanism for renal effects of PPV and PEEP
Transmission of ______ pressure to _____ space leading to: decreased __, ____, & __
Decreased CO leads to _______ increase in symapthetic tone with renal _____ & ____ conservation.
Decreased filling volume reduces ___ secretion with subsequent increases in ______, ______ and ____activity
|
|
Definition
transmission of intrapleural pressure to intravascular space leading to:
decreased VR, filling pressure, and CO
decreased CO leads to baroreceptor-mediated increase in symapthetic tone with renal vasoconstriction and Na/water conservation
decreased filling volume reduces ANP secretion with subsequent increases in sympathetic tone, renin activation and AVP activity
|
|
|
Term
How can the effect of PPV & PEEP be attenuated? |
|
Definition
effect can be attenuated by adequate fluid load and maintenance of CO |
|
|
Term
Does nitro or nitroprusside decrease RBF the most? Why? |
|
Definition
Nipride
-reduces RBF the most
Nitroglycerin
- produces less reduction in RBF than Nipride
DECREASED BP |
|
|
Term
How does Nipride affect the renal system?
Per lec what are the 2 major concerns/risks with deliberate hypotension? |
|
Definition
decreases renal vascular resistance, but shunts blood away from the kidneys
produces significant RAAS activation and catecholamine release
1. Periop vision loss 2. decrease RBF |
|
|
Term
*What are 2 major predictors of ARF following aortic surgery? |
|
Definition
preexisting renal dysfunction
periop hemodynamic instability |
|
|
Term
What is the incidence of ARF in AAA repair?
overall
elective
ruptured
Which of the above has highest incidence? Why? |
|
Definition
overall: 12%
elective: 4%
ruptured: 26%
Ruptured AAA repair has highest incidence of ARF b/c they were HD unstable to begin with |
|
|
Term
With a suprarenal or infrarenal aortic cross-clamp, what happens to RBF?
What is seen immediately following release? Despite the above what is the GFR at 2 and 24hrs post release compared to control?
What if clamp times are longer than 50-60 minutes? |
|
Definition
RBF decreased to ~50% of normal
following release:
RBF increases to supranormal levels (reflex hyperemia)
at 2 hours GFR remains ~1/3 of control values
at 24 hours GFR still only ~2/3 of control values
clamp times longer than 50-60 minutes may produce prolonged decrease in GFR |
|
|
Term
Is there evidence that some drugs may provide renal protection during cross-clamp?
*Is there evidence to support the use of mannitol or low dose dopamine to prevent renal injury with aortic cross-clamping?
What intervention is more important to attenuate the residual decreased in GFR following release of cross-clamp? |
|
Definition
controversy exists
little evidence to support the use of mannitol or low dose dopamine to prevent renal injury with aortic cross-clamping
FLUID LOADING |
|
|
Term
Is there renal dysfuntion and/or acute renal failure associated with procedures involving CPB?
If so what is incidence? |
|
Definition
YES
7% renal dysfunction
2% Acute Renal Failure |
|
|
Term
Is pulsatile flow in CPB advantageous? |
|
Definition
?? plasma renin activity is suppressed, however postop renal function is not improved |
|
|
Term
What drugs can be used in CPB; is there evidence that outcome are improved? |
|
Definition
Mannitol
Dopamine
no, little evidence that outcome are improved |
|
|
Term
*In CPB, what is most highly correlated with postop renal dysfunction? |
|
Definition
postop cardiac dysfunction
preop serum creatinine >1.9mg/dl |
|
|
Term
What patients are particularly susceptible to renal dysfunction
Renal dysfunction or failure may occur in up to _____ of patients following liver transplant
Obstructive jaundice is indicated by... |
|
Definition
hepatic failure/obstructive jaundice
renal dysfunction or failure may occur in up to 2/3 of patients following liver transplant
bilirubin levels of 35mg/dl (clog up kidneys)
|
|
|
Term
How can you prevent renal dysfunction in patients with Hepatic Failure/obstructive jaundice? (2)
Which method has better evidence to support it? |
|
Definition
preoperative hydration
low-dose dopamine
low dose dopamine has shown no advantage over preop hydration |
|
|
Term
What is the typical presentation of nephrotoxic ARF?
Nephrotoxic kidney failure means the kidneys are failing b/c of _____ not just decreased perfusion. |
|
Definition
non-oliguric with decreased concentrating ability
some toxic substance |
|
|
Term
What is Aminoglycosides nephrotoxicity directly related to?
How can this be reduced? |
|
Definition
directly related to high trough levels
may be reduced by once daily dosing |
|
|
Term
How can NSAIDs produce nephrotoxic insults? |
|
Definition
during stress, impaired prostaglandin activity due to NSAIDs results in failure of their protective activity, with subsequent decrease in RBF & GFR
(stress activates SNS & vasoconstriction, prostaglandins can help oppose those some - this protective mechanism blocked w NSAID use) |
|
|
Term
When is Cyclosporine used and what is it?
How can it cause a nephrotoxic insult?
Concurrent _________ may allow a dosage reduction & reduce incidence of ATN. |
|
Definition
immunosuppressive agent used extensively following organ transplant
induces SNS hyperreactivity, hypertension, and renal vasoconstriction
Concurrent calcium channel blockade may allow a dosage reduction & reduce incidence of ATN |
|
|
Term
*What is the mechanism of nephrotoxic injury with radiocontrast dyes? (2) |
|
Definition
microvascular obstruction
direct tubular toxicity |
|
|
Term
When can nephrotoxic insult risks be markedly increased with the use of radiocontrast dyes?
Is it ok to procede w/ surgery during this time?
|
|
Definition
in diabetic RI, hypovolemia, CHF
and/or
with a secondary insult (surgery) in the first 3-5 days following radiocontrast
-elective surgery should be postponed during this time period |
|
|
Term
What drugs given prophylactically with radiocontrast dye may offer some renal protection? |
|
Definition
N-Acetylcysteine
Fenoldopam |
|
|
Term
List 3 types of pigment nephropathy |
|
Definition
Rhabdomyalysis
hemolysis
Jaundice |
|
|
Term
How does Rhabdomyalysis produce a pigment nephropathy?
How can hemolysis cause renal damage?
(fyi no star for this slide =-) |
|
Definition
myoglobin transformed to ferrihematin and precipitates in the proximal tubules
secondary to RBC stroma deposition |
|
|
Term
How does jaundice cause nephrotoxic insults to the kidneys? |
|
Definition
at conjugated bilirubin >8mg/dl, bile salt excretion ceases and portal septicemia occurs
circulating endotoxins induce renal vasoconstriction |
|
|
Term
What are the general goals for anesthetic management of pts with renal issues or to prevent renal issues: (3) |
|
Definition
1. Maintain renal blood flow with adequate perfusion pressure
2. Suppress the vasoconstricting, salt retaining response to surgical stimulation & pain
3. Avoid or minimize nephrotoxic insults |
|
|
Term
List the concerns that should be considered for preoperative evaluation of a renal pt.
*print or review table on slide 57 |
|
Definition
Anemia
Blood volume status
Coagulopathy
Continue antihypertensives
Blood glucose
Last dialysis
(best within 24hrs of surgery)
Serum K
ABCC BLS
|
|
|
Term
What should be considered during induction regarding a possible full stomach? |
|
Definition
usual indications (pt just ate a big mac)
delayed gastric emptying d/t uremia
diabetic gastroparesis |
|
|
Term
During induction, it is important to _____!!!
What is uremia?
Uremia and/or antihypertensive use by the pt will cause them to have a _____ responsive SNS. What do you need to watch out for d/t this? |
|
Definition
TITRATE INDUCTION SLOWLY
uremia is a term used to loosely describe the illness accompanying kidney failure, in particular the increased nitrogenous waste products associated with the failure of this organ.
Less responsive SNS so watch out for bigger drops in BP with induction then normal
|
|
|
Term
Why else may you see an exaggerated drop in BP during induction? |
|
Definition
PPV
position changes
blood loss
drug-incuded myocardial depression |
|
|
Term
What VIA should be avoided with renal disease?
List 2 Advantages and Disadvantages of VIA with renal disease? |
|
Definition
avoid Sevo (risk for Compound A)
Advantages:
easily titratable (great for breakthrough HTN)
allows reduction in dose of MR which might have prolonged duration with renal disease
Disadvantages:
high incidence of concurrent hepatic disease with renal pts
risk of depression of CO by VIA |
|
|
Term
What are the advantages of opioids for maintenance of anesthesia?
Disadvantages?
Which opioid is very titratable?
T/F multiple anesthestic routes are okay?
List an example of TIVA technique |
|
Definition
Advantages
less myocardial depression
avoid concerns over hepato- & nephrotoxicity
Disadvantages
less able to control BP elevations
not as titratable (as VIAs)
Remifentanyl
TRUE
TIVA: Propofol + Remi + Cisatracurium |
|
|
Term
What MR are renally excreted?
What about reversal agents?
T/F prolongation of both MR & reversal agent is similar, so no real increase in risk for re-curarization with renal disease? |
|
Definition
Vecuronium
Rocuronium
Pancuronium
Neostigmine, Edrophonium, Pyridostigmine
true per lec |
|
|
Term
What MR clearance is independent of renal function? |
|
Definition
Mivacurium
Atracurium
Cisatracurium
MAC |
|
|
Term
Succs is safe to use with renal patients...
2 exceptions? |
|
Definition
Extensive neuropathy
High or high-normal serum K+ |
|
|
Term
What antihypertensives are unaffected by impaired renal function? (4)
*said in class to just read over this... |
|
Definition
Propranolol
Labetalol
Esmolol
Calcium Channel Blockers |
|
|
Term
What antihypertensives are affected by impaired renal function? (4)
*said in class to just read over this... |
|
Definition
Furosemide
Thiazide diruectics
Methyldopa
Guanethidine |
|
|
Term
What changes are seen with antihypertensive drugs used for deliberate hypotensive anesthesia technique with renal pts?
Trimethaphan - __________
Nitroglycerin - ___________
Nitroprusside - ___________
Hydralazine - _____________
|
|
Definition
*in class said just to read this.......
Trimethaphan - unchanged
Nitroglycerin - unchanged
Nitroprusside - potential for thiocyanate toxicity
Hydralazine - prolonged
Esmolol - unchanged |
|
|
Term
What vasopressors can be used for hypotension but has the greatest negative impact on the renal vasculature?
What vasopressors are preferred with renal pts?What is the risk with these? |
|
Definition
Phenylephrine is effective but has
greatest negative impact on renal vasculature so it would not be your first choice.
B-adrenergic agonists - preferable,
but may increase myocardial irritability |
|
|
Term
What is the ideal way to correct hypotension?
What if this doesn't work, then what? |
|
Definition
ideally blood volume expansion
but if unsuccessful:
B-adrenergic agonists
Dopamine |
|
|
Term
What fluids should be avoided for fluid management/UOP of renal pts?
What is typically course of action with severe renal dysfunction, but not ESRD?
|
|
Definition
Avoid K containing fluids (LR)
preop hydration may be helpful
typically NS is used, sometimes 1/2 NS |
|
|
Term
What is the most likely etiology of decreased UOP?
How can you correct this? |
|
Definition
most likely etiology is inadequate circulating fluid volume
likely to respond to fluid bolus
assure adequate intravascular fluid replacement prior to using mannitol or lasix to stimulate output |
|
|
Term
What is not predictive of postop renal function?
What condition narrows the margin of safety for a fluid challenge? |
|
Definition
Intraop UOP is not predictive
ESRD - tend to be more restrictive with fluids |
|
|
Term
Where should arterial lines possibly be avoided with renal pts? |
|
Definition
some people suggest avoiding the radial and ulnar arteries due to potential need for an AV fistula in the future
pressures & gases will be inaccurate if placed in same arm as their fistula |
|
|
Term
Why should you use strict asepsis when placing a central line?
What should are 2 options for monitoring volume status intraop? |
|
Definition
renal pts are extremely prone to infection
CVP vs PA cath
decide which based on underlying disease processes |
|
|
Term
What may be used, but is not ideal if IV access is difficult?
What should you be aware of when accessing these ports/caths? |
|
Definition
portocath or temporary dialysis catheter
strict asepsis
must aspirate left heparin before use
re-heparinized line when done using it |
|
|
Term
What should you be aware of/concerned with when positioning a renal patient?
Poor nutrition = _________
____ must be protected and well padded
May want access to ____ for periodic _____
|
|
Definition
Poor nutrition = fragile skin
Fistulas must be protected and well padded
May want access to fistula for periodic palpation |
|
|
Term
Where should you avoid IV access with pts approaching ESRD? |
|
Definition
avoid veins of non-dominant arm b/c will use this are for fistula placement |
|
|
Term
What are the advantages of a brachial plexus block for shunt placement? (3) |
|
Definition
ideal surgical conditions secondary to vasodilation
good postop analgesia
avoids many of the concerns with GETA |
|
|
Term
What are the disadvantages of a brachial plexus block for shunt placement? (4) |
|
Definition
1. must assure adequate coagulation
2. possible presence of preexisting diabetic or
uremic neuropathies
(document if present so it will be evident that they weren't caused by block)
3. metabolic acidosis lowers seizure threshold
following an intravasuclar injection
4. duration may be shorter? Ron has never seen this |
|
|
Term
What are the considerations for postop management?
Inadequate reversal of ________ if weakness is apparent.
Smaller doses of narcs, particularly: _______.
Continuous _______ monitoring
Continued supplemental _____, particularly if anemic
When do they next need _______?
|
|
Definition
Inadequate reversal of MR if weakness is apparent
Smaller doses of narcs, particularly: Morphine & Demerol (M3/M6 & Normeperidine metabolites)
Continuous EKG monitoring
Continued supplemental oxygen, particularly if anemic
When do they next need dialysis? |
|
|
Term
What are the most common causes of ESRD, which will lead to a renal transplant? (4) |
|
Definition
diabetes mellitis
glomerulonephritis
polycystic kidney disease
systemic hypertension |
|
|
Term
How long can a harvested kidney be preserved before it must be grafted into a pt? |
|
Definition
preserved, cold & perfused, for up to 48 hours |
|
|
Term
Where is a donor kidney placed?
How does it receive blood supply?
|
|
Definition
placed in lower abdomen
blood supply from iliac vessels
ureter anastomosed to bladder |
|
|
Term
What drug selection is ideal for a renal transplant?
What are the 2 critical aspects of anesthetic management with renal transplant?
What monitor is usually used to help evaluate fluid status? |
|
Definition
drug selection as previously described for all renal issues
maintenance of euvolemia & adequate perfusion pressure is critical
CVP monitoring is usually helpful |
|
|
Term
How is mannitol useful with renal transplants? |
|
Definition
osmotic diuresis with mannitol facilitates urine formation by transplanted kidney without relying on renal tubular mechanisms
(the transplant takes a little while to start functioning once placed) |
|
|
Term
What substances are released when vascular clamps are released after a renal transplant?
What does this cause and how do you treat it? |
|
Definition
release of K & acid metabolites (vasodilating) into circulation
Hypotension d/t:
1. Vasodilating substances released(transient)
2. Addition of ~300mL new capacity of intravascular space within new kidney
hypotension usually responds to fluid bolus |
|
|
Term
How should a patient with a transplanted kidney presenting for surgery be managed?
What 4 aspects should be considered? |
|
Definition
Should be managed as described for a patient with chronic renal insufficiency/failure
- appropriate drug selection
- maintenance of fluid volume & perfusion
- strict asepsis d/t immunosuppression
- consideration of coexisting disease (ie DM, CV disease)
|
|
|
Term
In ARF, a deterioration of renal funciton occurs over _____ or ______.
ARF results in inability of kidneys to? (2) |
|
Definition
hours or days
inability to maintain fluid & electrolyte homeostasis
inability to excrete nitrogenous wastes |
|
|
Term
What are 3 common definitions of ARF? |
|
Definition
increase in serum creatinine >0.5mg/dl
50% decrease in creatinine clearance
decreased function resulting in need for dialysis |
|
|
Term
What is oliguric and non-oliguric ARF states defined as? |
|
Definition
Oliguric <400ml/day
Non-oliguric >400ml/day |
|
|
Term
What patient population has the highest risk for ARF? |
|
Definition
elderly patients with DM and baseline RI |
|
|
Term
The mortality rate of severe ARF has not improved significantly in past 50 years, due to ____, ____ patient population
If ARF is associated with ________ failure & severe ________ or ________ failure mortality is close to 50%.
If ______ is required, mortality exceeds 50%. |
|
Definition
The mortality rate of severe ARF has not improved significantly in past 50 years for severe ARF, due to older, sicker patient population
If ARF is associated with multiorgan failure and severe hypotension or respiratory failure mortality is close to 50%.
If dialysis required, mortality exceeds 50% |
|
|
Term
What are the 3 classifications of ARF?
|
|
Definition
|
|
Term
What is prerenal failure?
What causes renal failure? |
|
Definition
acute circulatory problems which impair renal perfusion
caused by primary or secondary renal disease, toxins, or pigments
|
|
|
Term
What is postrenal failure caused by? |
|
Definition
obstruction of the urinary tract
*chart on slide 77 but Ron said dont worry about it too much---but do causes of ARF on slide 78. |
|
|
Term
What is the supportive management of ARF? (2) |
|
Definition
limit further renal damage
correct H2O, electrolyte, acid-base imbalance |
|
|
Term
In the management of ARF, what underlying causes should be corrected? (3) |
|
Definition
hypovolemia
hypotension
sepsis |
|
|
Term
What fluids should be used for fluid resuscitation of ARF, which one is contraindicated?
Is Norepi a good choice for ARF hypotension?
Dopamine? |
|
Definition
crystalloid vs colloid
probably not HESPAN
(it may increase the risk of ARF in septic pts or pts w/ transplanted kidney)
Yes, Norepinephrine increases GFR more than other vasopressors per lec.
Dopamine - not bad but no definitive evidence that it decreases risk for ARF or really helps a lot per Ron. |
|
|
Term
*Are diuretics helpful in ARF? |
|
Definition
In general, attempts to convert oliguric to non-oliguric renal failure with diuretics are unsuccessful and potentially harmful
KEY IS VOLUME!! |
|
|
Term
What are 2 exceptions of diuretics being useful for ARF? |
|
Definition
post-transfusion ATN decreased inpatients who recieve mannitol in addition to adequate hydration
forced alkaline diuresis with mannitol useful in preventing ATN following renal crush injury |
|
|
Term
What may reduce ARF in high-risk patients who receive radiocontrast dye? |
|
Definition
N-acetylcysteine
Fenoldopam |
|
|
Term
Management of ARF (3 general) |
|
Definition
Diuretics
N-acetylcysteine/Fenoldopam
Dialysis |
|
|
Term
What is the most common cause of new-onset ARF in the postop period? |
|
Definition
|
|
Term
What is imparied in sepsis regarding the kidneys?
What is vasomotor nephropathy that occurs with sepsis? |
|
Definition
renal autoregulation
renal vasoconstriction in the presence of increased CI |
|
|
Term
What do hypotension & endotoxin in sepsis produce? (5) |
|
Definition
INCREASED:
sympathoadrenal stimulation
RAA stimulation
thromboxane
leukotrienes
PGF2 |
|
|
Term
The substances produced and systems stimulated by hypotension and endotoxins in sepsis leads to? (5) |
|
Definition
DECREASED:
renal blood flow
GFR
sodium excretion
UOP
further renal vasoconstriction |
|
|
Term
What is U63557A?
How does it protect the kidneys during sepsis? |
|
Definition
selective thromboxane synthetase inhibitor
protective effect against deterioration of creatinine clearance in animal sepsis model |
|
|
Term
Do NSAIDs provide renal protection in sepsis? |
|
Definition
decreases synthesis of renal vasodilating prostacyclin producing worsened renal function in sepsis |
|
|
Term
Is high-dose methylprednisolone effective for renal protection in sepsis?
|
|
Definition
shown not to be beneficial, and may, in fact worsen outcome by increasing protein catabolism and inhibiting phospholipase A2 thereby reducing production of vasodilatory prostaglandins |
|
|
Term
Is supranormal oxygen supplementation protective to the kidneys in sepsis?
Is low-dose Dopamine beneficial for renal protection in sepsis? |
|
Definition
Unclear
Renal DO2 & VO2 not tied to systemic values
↓renal DO2 doesn't appear to cause tubular injury
High dose inotropes may worsen injury
Widely used, but controversial as to its benefit:
combined with phenylephrine, it increases RBF in non-specific patients, but not in sepsis
Large study looked at Dopamine 2mcg/kg/min vs placebo in sepsis & found no difference in serum creatinine, need for dialysis, ICU stay, or mortality |
|
|
Term
What patients may benefit from Norepinephrine in sepsis?
Goal of BP with this treatment?
Benefits of NE? (3) |
|
Definition
patients with septick shock, hypotension, & oliguria may benefit from addition of NE
to maintain MAP >60mmHg
Benefits:
increased SV
decreased HR
increased GFR
*remember NE causes positive inotropy and vasoconstrictor but only has a transient increase in HR |
|
|
Term
When is NE be particularly adventageous in sepsis? |
|
Definition
for patients whom high-dose Dopamine can be weaned off by substitution with NE
*Dopamine = much larger inc. in HR |
|
|
Term
In sepsis, why may high doses of NE be required? |
|
Definition
Due to refractoriness of peripheral vasculature secondary to massive release of NO and vasopressin deficiency |
|
|
Term
When do patients have low plasma levels of AVP? |
|
Definition
patients in vasodilatory shock
hypotension, increased CI, decreased SVR |
|
|
Term
In vasodilatory shock, what is AVP deficiency likely a result of? |
|
Definition
excessive baroreceptor-mediated release following sustained hypotension
(stores in posterior pituitary get used up) |
|
|
Term
Is an infusion of AVP beneficial in sepsis?
How does it work? |
|
Definition
In one study, infusion of AVP at 2.4U/hr increased systolic BP from 92-146mmHg and allowed discontinuation of catecholamine infusions
additional effect on vascular smooth muscle K+ ATP channels restoring their sensitivity to norepinephrine |
|
|